Insulin with a stable basal release profile

2011-5-12
Pohl, Roderike
Kashyap, Nandini
Hauser, Robert
Özhan, Koray
A basal insulin formulation composed of insulin, preferably insulin glargine, injectable zinc and injectable iron compounds as precipitating and/or stabilizing agents has been developed for subcutaneous, intradermal or intramuscular administration. The formulation is designed to form a precipitate of insulin following injection, creating a slow releasing "basal insulin" over a period of 12 to 24 hours.
Citation Formats
R. Pohl, N. Kashyap, R. Hauser, and K. Özhan, “Insulin with a stable basal release profile,” 00, 2011.